The hidden alternative: getting investigational treatments off-study
- 1 January 2003
- journal article
- Published by Elsevier in The Lancet
- Vol. 361 (9351) , 63-67
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Arizona's Cancer Clinical Trials Law: Flawed Process, Flawed ProductHastings Center Report, 2001
- Quantitative Analysis of Ethical Issues in Phase I Trials: A Survey Interview Study of 144 Advanced Cancer PatientsIRB: Ethics & Human Research, 2000
- High-Dose Chemotherapy plus Autologous Bone Marrow Transplantation for Metastatic Breast CancerNew England Journal of Medicine, 2000
- Conventional-Dose Chemotherapy Compared with High-Dose Chemotherapy plus Autologous Hematopoietic Stem-Cell Transplantation for Metastatic Breast CancerNew England Journal of Medicine, 2000
- The Effect of Raloxifene on Risk of Breast Cancer in Postmenopausal WomenJAMA, 1999
- Is Informed Consent Always Necessary for Randomized, Controlled Trials?New England Journal of Medicine, 1999
- A Response to a Purported Ethical Difficulty with Randomized Clinical Trials Involving Cancer PatientsThe Journal of Clinical Ethics, 1992